189 related articles for article (PubMed ID: 28427501)
1. The cancer stem cell phenotype as a determinant factor of the heterotypic nature of breast tumors.
Fonseca NA; Cruz AF; Moura V; Simões S; Moreira JN
Crit Rev Oncol Hematol; 2017 May; 113():111-121. PubMed ID: 28427501
[TBL] [Abstract][Full Text] [Related]
2. Nucleolin overexpression in breast cancer cell sub-populations with different stem-like phenotype enables targeted intracellular delivery of synergistic drug combination.
Fonseca NA; Rodrigues AS; Rodrigues-Santos P; Alves V; Gregório AC; Valério-Fernandes Â; Gomes-da-Silva LC; Rosa MS; Moura V; Ramalho-Santos J; Simões S; Moreira JN
Biomaterials; 2015 Nov; 69():76-88. PubMed ID: 26283155
[TBL] [Abstract][Full Text] [Related]
3. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer.
Duhachek-Muggy S; Qi Y; Wise R; Alyahya L; Li H; Hodge J; Zolkiewska A
Mol Cancer; 2017 Feb; 16(1):32. PubMed ID: 28148288
[TBL] [Abstract][Full Text] [Related]
4. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer stem cells: an update.
Iqbal J; Chong PY; Tan PH
J Clin Pathol; 2013 Jun; 66(6):485-90. PubMed ID: 23322821
[TBL] [Abstract][Full Text] [Related]
6. LncRNA-Hh Strengthen Cancer Stem Cells Generation in Twist-Positive Breast Cancer via Activation of Hedgehog Signaling Pathway.
Zhou M; Hou Y; Yang G; Zhang H; Tu G; Du YE; Wen S; Xu L; Tang X; Tang S; Yang L; Cui X; Liu M
Stem Cells; 2016 Jan; 34(1):55-66. PubMed ID: 26418365
[TBL] [Abstract][Full Text] [Related]
7. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.
Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M
Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039
[TBL] [Abstract][Full Text] [Related]
8. Breast-cancer stem cells-beyond semantics.
Badve S; Nakshatri H
Lancet Oncol; 2012 Jan; 13(1):e43-8. PubMed ID: 22225725
[TBL] [Abstract][Full Text] [Related]
9. Dormant tumor cells expressing LOXL2 acquire a stem-like phenotype mediating their transition to proliferative growth.
Weidenfeld K; Schif-Zuck S; Abu-Tayeh H; Kang K; Kessler O; Weissmann M; Neufeld G; Barkan D
Oncotarget; 2016 Nov; 7(44):71362-71377. PubMed ID: 27655685
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity and Plasticity of Breast Cancer Stem Cells.
Sousa B; Ribeiro AS; Paredes J
Adv Exp Med Biol; 2019; 1139():83-103. PubMed ID: 31134496
[TBL] [Abstract][Full Text] [Related]
11. Lung cancer stem cells: origin, features, maintenance mechanisms and therapeutic targeting.
Heng WS; Gosens R; Kruyt FAE
Biochem Pharmacol; 2019 Feb; 160():121-133. PubMed ID: 30557553
[TBL] [Abstract][Full Text] [Related]
12. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
13. Road to stemness in hepatocellular carcinoma.
Flores-Téllez TN; Villa-Treviño S; Piña-Vázquez C
World J Gastroenterol; 2017 Oct; 23(37):6750-6776. PubMed ID: 29085221
[TBL] [Abstract][Full Text] [Related]
14. TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development.
Czerwińska P; Shah PK; Tomczak K; Klimczak M; Mazurek S; Sozańska B; Biecek P; Korski K; Filas V; Mackiewicz A; Andersen JN; Wiznerowicz M
Oncotarget; 2017 Jan; 8(1):863-882. PubMed ID: 27845900
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma.
Jayachandran A; Dhungel B; Steel JC
J Hematol Oncol; 2016 Aug; 9(1):74. PubMed ID: 27578206
[TBL] [Abstract][Full Text] [Related]
16. Transcription factors associated with epithelial-mesenchymal transition and cancer stem cells in the tumor centre and margin of invasive breast cancer.
Alkatout I; Wiedermann M; Bauer M; Wenners A; Jonat W; Klapper W
Exp Mol Pathol; 2013 Feb; 94(1):168-73. PubMed ID: 22985790
[TBL] [Abstract][Full Text] [Related]
17. Cytokines driving breast cancer stemness.
Chin AR; Wang SE
Mol Cell Endocrinol; 2014 Jan; 382(1):598-602. PubMed ID: 23562748
[TBL] [Abstract][Full Text] [Related]
18. Non-coding RNAs as potential therapeutic targets in breast cancer.
Tomar D; Yadav AS; Kumar D; Bhadauriya G; Kundu GC
Biochim Biophys Acta Gene Regul Mech; 2020 Apr; 1863(4):194378. PubMed ID: 31048026
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer.
Tsang JY; Huang YH; Luo MH; Ni YB; Chan SK; Lui PC; Yu AM; Tan PH; Tse GM
Breast Cancer Res Treat; 2012 Nov; 136(2):407-17. PubMed ID: 23053657
[TBL] [Abstract][Full Text] [Related]
20. Modeling of Cancer Stem Cell State Transitions Predicts Therapeutic Response.
Sehl ME; Shimada M; Landeros A; Lange K; Wicha MS
PLoS One; 2015; 10(9):e0135797. PubMed ID: 26397099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]